2m 2m 2m 2m 2m 2m 2m
BOLT BIOTHERAP (BOLT)
NASDAQ
$4.64+$0.005 (+0.11%)
Price as of Jun 03, 2026 4:10 PM EDT- $10.1MMarket Cap
- -15.82%1-Year Change
- BiotechnologyIndustry
BOLT BIOTHERAP (BOLT)
$4.64+$0.005 (+0.11%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 7.7M +0.07% | 7.7M -2.36% | 7.9M +37.48% | 5.7M +354.68% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 7.7M +0.07% | 7.7M -2.36% | 7.9M +37.48% | 5.7M +354.68% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -28.5M -50.35% | -57.5M -6.62% | -61.5M -15.84% | -73.1M -3.35% | |
Depreciation and Amortization Expense | 1.3M -27.51% | 1.8M -3.94% | 1.9M +11.28% | 1.7M +39.65% | |
Total Operating Expenses | 43.8M -45.74% | 80.7M -3.97% | 84.1M -12.47% | 96.0M +2.13% | |
Operating Profit | -36.1M -50.56% | -73.0M -4.13% | -76.2M -15.64% | -90.3M -2.66% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 2.7M -72.44% | 9.9M +41.88% | 7.0M +214.84% | 2.2M +138.31% | |
Income before Taxes | -36.1M -50.56% | -73.0M -4.13% | -76.2M -15.64% | -90.3M -2.66% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | 0 -100.00% | 1.5M N/A | 0 N/A | 0 N/A | |
Net Income | -33.4M -47.12% | -63.1M -8.79% | -69.2M -21.45% | -88.1M -10.64% | |
Net Income from Continuing Operations Applicable to Common | -33.4M -47.12% | -63.1M -8.79% | -69.2M -21.45% | -88.1M -10.64% | |
Basic EPS and Net Income | -17.85 +981.82% | -1.65 -9.84% | -1.83 -22.46% | -2.36 -20.54% | |
Diluted EPS and Net Income | -17.85 +981.82% | -1.65 -9.84% | -1.83 -22.46% | -2.36 -20.54% | |
Basic Weighted Average Shares | 1.9M -95.10% | 38.2M +0.98% | 37.8M +1.21% | 37.4M +12.54% | |
Diluted Weighted Average Shares | 1.9M -95.10% | 38.2M +0.98% | 37.8M +1.21% | 37.4M +12.54% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 11.7M +62.43% | 7.2M -33.35% | 10.8M +16.94% | 9.2M -66.24% | |
Short-Term Investments | 15.8M -60.61% | 40.1M -56.10% | 91.4M -42.76% | 159.6M +0.51% | |
Cash and Cash Equivalents and Short-Term Investments | 27.5M -41.88% | 47.3M -53.69% | 102.2M -39.49% | 168.9M -9.31% | |
Total Current Assets | 30.3M -40.45% | 50.8M -51.93% | 105.7M -38.81% | 172.7M -8.68% | |
Accumulated Depreciation | 7.4M +1.50% | 7.3M +26.53% | 5.8M +46.92% | 3.9M +74.39% | |
Property and Plant and Equipment and Net | 1.2M -60.34% | 3.1M -36.68% | 5.0M -23.18% | 6.5M +4.79% | |
Total Long-Term Assets | 138,000 +122.58% | 62,000 -96.60% | 1.8M +77.14% | 1.0M -1.34% | |
Total Assets | 56.7M -43.04% | 99.6M -37.65% | 159.8M -29.86% | 227.8M -25.97% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 8.4M -46.80% | 15.9M -22.49% | 20.5M -11.51% | 23.1M +8.39% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 132,000 N/A | 0 -100.00% | 43,000 +2.38% | 42,000 -80.00% | |
Total Liabilities | 30.2M -28.73% | 42.4M -9.80% | 47.0M -16.44% | 56.3M -2.25% | |
Retained Earnings | -460.8M +7.81% | -427.4M +17.33% | -364.3M +23.45% | -295.1M +42.56% | |
Total Stockholders Equity | 26.5M -53.66% | 57.2M -49.27% | 112.7M -34.26% | 171.5M -31.43% | |
Total Shares Outstanding | 1.9M -94.99% | 38.3M +0.59% | 38.1M +0.84% | 37.8M +1.06% | |
Cash Flow | |||||
Cash from Operating Activities | -39.9M -34.98% | -61.3M -11.85% | -69.5M -9.12% | -76.5M +34.06% | |
Capital Expenditures | 72,000 +75.61% | 41,000 -80.10% | 206,000 -89.45% | 2.0M -16.47% | |
Cash from Investing Activities | 44.3M -23.05% | 57.6M -18.95% | 71.0M +22.77% | 57.9M +124.92% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 19,000 -82.41% | 108,000 -57.31% | 253,000 -49.70% | 503,000 -99.84% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -469.30% -50.59% | -949.91% -1.81% | -967.45% -38.64% | -1,576.56% N/A | |
Return on Assets | -42.69% -12.28% | -48.66% +36.28% | -35.71% +8.52% | -32.90% N/A | |
Return on Equity | -79.75% +7.36% | -74.28% +52.57% | -48.69% +16.51% | -41.79% N/A | |
Revenue Growth | 0.07% +102.75% | -2.36% -106.30% | 37.48% -89.43% | 354.68% N/A | |
Current Ratio | 3.59 +11.94% | 3.20 -37.98% | 5.17 -30.84% | 7.47 N/A | |
Cash Ratio | 1.39 +205.33% | 0.45 -14.02% | 0.53 +32.16% | 0.40 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow